|
|
|
Volumn 61, Issue 64, 2001, Pages 56-62
|
|
Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen® support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant
a
|
|
Author keywords
Chemotherapy; Monoclonal antibody; Non Hodgkin's lymphoma; Rituximab; Stem cell transplant
|
|
Indexed keywords
CARBOPLATIN;
ETOPOSIDE;
IFOSFAMIDE;
MESNA;
MITOXANTRONE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RITUXIMAB;
ANTINEOPLASTIC AGENT;
CD34 ANTIGEN;
MONOCLONAL ANTIBODY;
RIME REGIMEN;
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS;
ADULT;
AGED;
B CELL LYMPHOMA;
CANCER RECURRENCE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
FEMALE;
HUMAN;
MALE;
NEUROTOXICITY;
NONHODGKIN LYMPHOMA;
PATIENT SELECTION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
ARTICLE;
AUTOTRANSPLANTATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
LEUKAPHERESIS;
METHODOLOGY;
MIDDLE AGED;
REMISSION;
STEM CELL MOBILIZATION;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD34;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ETOPOSIDE;
FEMALE;
FILGRASTIM;
HEMATOPOIETIC STEM CELL MOBILIZATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IFOSFAMIDE;
LEUKAPHERESIS;
LYMPHOMA, B-CELL;
MALE;
MIDDLE AGED;
MITOXANTRONE;
REMISSION INDUCTION;
TRANSPLANTATION, AUTOLOGOUS;
|
|
EID: 0034743477
PISSN: 09024506
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (22)
|
